Marshall Wace, LLP Inogen Inc Transaction History

Marshall Wace, LLP

$81.7 Billion
Q2 2025

A detailed history of Marshall Wace, LLP transactions in Inogen Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 26,181 shares of INGN stock, worth $213,898. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,181

Previous 42,185 37.94%

Holding current value

$213,898

Previous $300,000 38.67%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$5.75 - $7.32 $92,023 - $117,149	-16,004 Reduced 37.94%	26,181 $184,000
Q1 2025 May 15, 2025	BUY	$6.8 - $12.53 $113,192 - $208,574	16,646 Added 65.18%	42,185 $300,000
Q4 2024 Feb 13, 2025	BUY	$8.31 - $11.09 $212,229 - $283,227	25,539 New	25,539 $234,000
Q2 2024 Aug 14, 2024	SELL	$6.3 - $8.95 $1.29 Million - $1.83 Million	-204,107 Reduced 61.98%	125,205 $1.02 Million
Q1 2024 May 15, 2024	BUY	$5.26 - $10.15 $1.28 Million - $2.47 Million	243,400 Added 283.31%	329,312 $2.66 Million
Q4 2023 Feb 14, 2024	SELL	$4.21 - $6.32 $180,541 - $271,026	-42,884 Reduced 33.3%	85,912 $471,000
Q3 2023 Nov 14, 2023	SELL	$5.14 - $11.28 $929,779 - $2.04 Million	-180,891 Reduced 58.41%	128,796 $672,000
Q2 2023 Aug 14, 2023	BUY	$10.01 - $13.86 $3.1 Million - $4.29 Million	309,687 New	309,687 $3.58 Million
Q2 2021 Aug 13, 2021	BUY	$52.03 - $68.77 $648,970 - $857,768	12,473 New	12,473 $813,000
Q1 2021 May 17, 2021	SELL	$43.96 - $55.99 $414,806 - $528,321	-9,436 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$27.19 - $44.68 $1.99 Million - $3.27 Million	-73,271 Reduced 88.59%	9,436 $422,000
Q3 2020 Nov 16, 2020	BUY	$27.01 - $37.31 $2.23 Million - $3.09 Million	82,707 New	82,707 $2.4 Million
Q1 2020 May 15, 2020	SELL	$32.63 - $67.59 $15,564 - $32,240	-477 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$45.95 - $76.15 $2.92 Million - $4.83 Million	-63,486 Reduced 99.25%	477 $33,000
Q3 2019 Nov 14, 2019	BUY	$41.82 - $66.71 $656,072 - $1.05 Million	15,688 Added 32.5%	63,963 $3.07 Million
Q2 2019 Aug 14, 2019	SELL	$63.19 - $95.15 $461,602 - $695,070	-7,305 Reduced 13.14%	48,275 $3.22 Million
Q1 2019 May 14, 2019	BUY	$90.12 - $152.23 $3.22 Million - $5.44 Million	35,747 Added 180.24%	55,580 $5.3 Million
Q4 2018 Feb 14, 2019	BUY	$112.83 - $239.74 $2.24 Million - $4.75 Million	19,833 New	19,833 $2.46 Million
Q2 2018 Aug 14, 2018	SELL	$123.8 - $192.48 $480,096 - $746,437	-3,878 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$114.22 - $133.22 $442,945 - $516,627	3,878 New	3,878 $476,000

Others Institutions Holding INGN

# of Institutions

134

Shares Held

20.8M

Call Options Held

17.3K

Put Options Held

10K

View Full List

About Inogen Inc

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $187M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

More about INGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Inogen Inc Transaction History